npj Schizophrenia Impact Factor
The Schizophrenia International Research Society's (SIRS) partner journal, npj Schizophrenia, received an Impact Factor of 5.200 on Tuesday, 30 June. While an impact factor is not the only measure of success, SIRS is pleased to see the increase from the journals first Impact Factor at 4.304 just last year. The journal has a ranking if 32 of 156 in psychiatry journals. npj Schizophrenia is part of the Nature Partner Journals series and is published by Springer Nature in partnership with SIRS.

npj Schizophrenia Editor-in-Chief, James H. Meador-Woodruff, stated, "It is exciting for our society journal, npj Schizophrenia, to have received our second annual impact factor and to have seen this increase from 4.304 last year to our most recent impact factor of 5.200. That the journal has reached this point in a relatively short period of time is in large part due to our members supporting this new journal and submitting high quality research for publication. My sincerest thanks for those of you that have been part of this journey to date, as authors, peer reviewers, and editorial board members. Now that we have achieved this level of growth, I hope that all of you will consider npj Schizophrenia as a journal in which to publish. Continuing to publish outstanding research from members of our society will be important as we take this journal to the next level." 

npj Schizophrenia is an open access, online-only journal that aims to publish high-quality original papers and review articles relevant to all aspects of schizophrenia and psychosis, from molecular and basic research through environmental or social research, to translational and treatment-related topics. npj Schizophrenia publishes papers on the broad psychosis spectrum including affective psychosis, bipolar disorder, the at-risk mental state, psychotic symptoms, and overlap between psychotic and other disorders.

All SIRS members are entitled to a discounted APC (50% reduction on the full rate) if an article for which they are the corresponding author is accepted for publication within the journal.

Visit the website to explore all content available:
The Schizophrenia International Research Society (SIRS) was founded in 2005 with the goal of bringing together scientists from around the world to exchange the latest advances in biological and psychosocial research in schizophrenia. SIRS is committed to providing a forum for the exchange of scientific information, which is critical for the advancement and translation of scientific discovery in schizophrenia and related disorders. Part of the mission of the Society is exchange the latest advances in research and facilitate the application of these findings to clinical practice and treatment.